HR Execs on the Move

GenMark Diagnostics

www.genmarkdx.com

 
In 1993, a novel technology was invented by a team that included Jon Faiz Kayyem, PhD at The California Institute of Technology (CalTech). This invention combined nucleic acids and microelectronics to produce an electronic sensor for DNA detection. His invention was based on electrical detection of nucleic acids on a cassette based detection platform. Dr. Kayyem went on to found Clinical Micro Sensors, with the goal of translating this “eSensor” technology to disposable chips. Following several acquisitions of the technology, Dr. Kayyem became actively involved again in 2009, returning as an investor and then as CEO and Chairman of the ...
  • Number of Employees: 100-250
  • Annual Revenue: $50-100 Million
  • www.genmarkdx.com
  • 5964 La Place Court Suite 100
    Carlsbad, CA USA 92008
  • Phone: 760.448.4300

Executives

Name Title Contact Details
David Barreca
Senior Director of Sales Profile
Jon Faiz Kayyem
SVP R&D Profile
Hollis Winkler
Vice President of Human Resources Profile
Bick Sellers
Director of Human Resources Profile

Similar Companies

NextStep Arthropedix

NextStep Arthropedix is a medical device manufacturer focused on designing, developing, manufacturing, and distributing joint replacement implant and instrument products for hip and knee arthroplasty. This company is at the forefront of designing and manufacturing innovative implants characterized by the advantages of 3D printing technology.

Bioness

Bioness offers award-winning medical devices designed to benefit people with stroke, Multiple Sclerosis, traumatic brain injury, Cerebral Palsy, and spinal cord injury. These products use electrical stimulation to help people regain mobility and

Precision Medical

Precision Medical is a Matthews, NC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Anrad Corporation

Anrad Corporation is a Saint-Laurent, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

NuVasive

NuVasive® is an innovative medical device company focused on developing minimally disruptive surgical products and procedures for the spine. Our mission is to improve the lives of patients who suffer from debilitating back, neck, or leg pain by creating cutting-edge products and procedures that revolutionize spine surgery through focusing on Speed of Innovation®, Absolute Responsiveness®, and Superior Clinical Results. Through innovative technological advancements, NuVasive has successfully progressed major spine surgery to where many patients have experienced extraordinary results—they are often walking the same day of surgery, experiencing less blood loss, spending less time in the hospital, and going back to work within four to six weeks (versus six months). NuVasive is the third largest medical device company in the global spine industry. We feature more than 90 products spanning lumbar, thoracic, and cervical applications, neuromonitoring services, and a biologics portfolio. Our products have been used in hundreds of thousands of spine surgeries. NuVasive had revenues of $811 million in 2015, including sales in over 30 countries, and employs more than 1,600 people globally. Corporate headquarters are in San Diego, California and Amsterdam, the Netherlands serves as international headquarters. The company has additional offices in the U.S. located in the states of Tennessee, Ohio, Maryland, and California. Internationally, NuVasive has additional offices located Puerto Rico, the United Kingdom, Germany, Italy, Australia, Spain, Singapore, and Japan.